Utah Code Title 26B. Utah Health and Human Services Codes § 26B-4-212. Institutional review board--Approved study of cannabis, a cannabinoid product, or an expanded cannabinoid product

(a) “Approved study” means a medical research study:

(b) “Board” means the Cannabis Research Review Board created in Section 26B-1-420.

(c) “Cannabinoid product” means the same as that term is defined in Section 58-37-3.6.

(d) “Cannabis” means the same as that term is defined in Section 58-37-3.6.

(e) “Expanded cannabinoid product” means the same as that term is defined in Section 58-37-3.6.

(f) “Institutional review board” or “IRB” means an institutional review board that is registered for human subject research by the United States Department of Health and Human Services.

(a) process a cannabinoid product or an expanded cannabinoid product;

(b) possess a cannabinoid product or an expanded cannabinoid product; and

(c) administer a cannabinoid product, or an expanded cannabinoid product to an individual in accordance with the approved study.

(a) import cannabis, a cannabinoid product, or an expanded cannabinoid product from another state if:

(b) obtain cannabis, a cannabinoid product, or an expanded cannabinoid product from the National Institute on Drug Abuse.

(a) the distribution complies with federal law; and

(b) the distribution is for the purposes of, and in accordance with, the approved study.